Caristo Diagnostics Names Stephen Deitsch as CEO
Caristo Diagnostics has appointed Stephen M. Deitsch as its new Chief Executive Officer, effective immediately, announced in a press release. Deitsch, a board member at Caristo, brings over 25 years of experience in medtech and healthcare leadership. He previously served as Chief Financial Officer at OrganOx, where he led the company's 2025 sale to Terumo Corporation for $1.5 billion.
Deitsch succeeds Frank Cheng, who has been named Chief Operating Officer after serving as CEO since 2023. During Cheng’s tenure, Caristo introduced its CaRi-Plaque analysis in the U.S. and advanced regulatory progress for its CaRi-Heart technology.
Caristo’s AI-based CaRi-Heart system, which detects coronary inflammation, is commercially available in the UK, Europe, and Australia. The company also received FDA clearance in 2025 for CaRi-Plaque, which provides plaque and stenosis quantification for U.S. hospitals, imaging centers, and research partners.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 McGraw Hill Adds AI Study Tools to Connect Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 ALTOUR Unveils AI Platform for Corporate Travel Decisions Oct 16 BOC Group Adds AI Assistant to ADOIT 21More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Cadent Names Lisa Utzschneider Interim CEO
Prologue Medicines names Stephen Harrison chief scientific officer
Notable Names Nicholas Desai Chief Medical Officer
Caruso Expands US Fund Administration Business From Dallas
CINC Systems Names Mike Mauseth President and COO
Daily AI Brief: the AI news that matters, in your inbox.